Witnessing the stock’s movement on the chart, on Thursday, Twist Bioscience Corp (NASDAQ: TWST) set off with pace as it heaved 3.31% to $46.87, before settling in for the price of $45.37 at the close. Taking a more long-term approach, TWST posted a 52-week range of $27.41-$60.90.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that the giant of the Healthcare sector posted annual sales growth of 42.89% over the last 5 years. Meanwhile, its Annual Earning per share during the time was 1.70%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 43.45%. This publicly-traded company’s shares outstanding now amounts to $59.58 million, simultaneously with a float of $56.31 million. The organization now has a market capitalization sitting at $2.80 billion. At the time of writing, stock’s 50-day Moving Average stood at $48.89, while the 200-day Moving Average is $46.51.
Twist Bioscience Corp (TWST) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Diagnostics & Research industry. Twist Bioscience Corp’s current insider ownership accounts for 5.60%, in contrast to 103.98% institutional ownership. According to the most recent insider trade that took place on Feb 07 ’25, this organization’s Director sold 2,940 shares at the rate of 53.13, making the entire transaction reach 156,217 in total value, affecting insider ownership by 18,173.
Twist Bioscience Corp (TWST) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.55 per share during the current fiscal year.
Twist Bioscience Corp’s EPS increase for this current 12-month fiscal period is 43.45% and is forecasted to reach -1.50 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 37.54% through the next 5 years, which can be compared against the 1.70% growth it accomplished over the previous five years trading on the market.
Twist Bioscience Corp (NASDAQ: TWST) Trading Performance Indicators
Let’s observe the current performance indicators for Twist Bioscience Corp (TWST). It’s Quick Ratio in the last reported quarter now stands at 4.62. The Stock has managed to achieve an average true range (ATR) of 3.23. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 8.47.
In the same vein, TWST’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -3.38, a figure that is expected to reach -0.55 in the next quarter, and analysts are predicting that it will be -1.50 at the market close of one year from today.
Technical Analysis of Twist Bioscience Corp (TWST)
Going through the that latest performance of [Twist Bioscience Corp, TWST]. Its last 5-days volume of 1.1 million indicated improvement to the volume of 0.85 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 16.71% While, its Average True Range was 3.23.
Raw Stochastic average of Twist Bioscience Corp (TWST) in the period of the previous 100 days is set at 54.44%, which indicates a major rise in contrast to 27.23% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 51.10% that was lower than 59.22% volatility it exhibited in the past 100-days period.
